Pooled safety analyses of ALK-TKI inhibitor in ALK-positive NSCLC

Zhu, Q; Hu, H; Weng, DS; Zhang, XF; Chen, CL; Zhou, ZQ; Tang, Y; Xia, JC

Xia, JC (reprint author), Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol Southern China, Guangzhou 510060, Guangdong, Peoples R China.; Xia, JC (reprint author), Sun Yat Sen Univ, Canc Ctr, Dept Biotherapy, Guangzhou 5100

BMC CANCER, 2017; 17 ( ):

Abstract

Background: The anaplastic lymphoma kinase tyrosine kinase inhibitors (ALK-TKIs) have been administered to patients with ALK-positive non-small cell l......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索